Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01934257
Other study ID # 3332-5
Secondary ID
Status Completed
Phase N/A
First received August 27, 2013
Last updated August 29, 2013
Start date June 1994
Est. completion date June 1996

Study information

Verified date August 2013
Source Mead Johnson Nutrition
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This clinical trial will determine if the formula given to infants experiencing fussiness, crying, cramping, gas, and/or diarrhea, is accepted and well tolerated and helps to resolve symptoms.


Recruitment information / eligibility

Status Completed
Enrollment 296
Est. completion date June 1996
Est. primary completion date June 1996
Accepts healthy volunteers No
Gender Both
Age group N/A to 12 Weeks
Eligibility Inclusion Criteria:

- Subject is between 2 and 12 weeks of age

- Subject has currently been receiving a milk-based lactose-containing formula for at least 5 days as the sole item of diet

- Subject has never switched to any lactose free formula

- The parent/guardian who will fill out the quality of life questionnaire is female and at least 18 years of age

- The parent/guardian has reported an unsolicited history of feeding problems including fussiness/crying/cramping, gas, or diarrhea

- Signed Informed Consent

Exclusion Criteria:

- Subject is in daycare for more than 4 hours per day (20 hours per week)

- Subject has serious perinatal complications, underlying disease or congenital malformations that impair normal formula feeding

- The parent/guardian who will fill out the quality of life questionnaire has chronic illness, e.g. diabetes, inflammatory bowel disease or other illness requiring daily medication or treatment

- Subject has acute infectious diarrhea or any other intercurrent illness

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)


Related Conditions & MeSH terms


Intervention

Other:
Marketed milk-based lactose-containing infant formula

Marketed milk-based lactose-free infant formula

Marketed soy-based lactose-free infant formula


Locations

Country Name City State
Canada Dr. David Conner Winnipeg Manitoba
United States Dr. Mark Pearlman Aurora California
United States Kentucky Pediatrics Bardstown Kentucky
United States Kids Med South Baton Rouge Louisiana
United States Chapel Hill Pediatrics Durham North Carolina
United States Welborn Clinic Peds Evansville Indiana
United States Henderson Pediatrics Fletcher North Carolina
United States Pediatric Medical Associates Havertown Pennsylvania
United States Riveria Pediatrics Indianapolis Indiana
United States Matthews Children Group Matthews North Carolina
United States Gould Medical Foundation Modesto California
United States The Pediatric Group Princeton New Jersey
United States Capital Pediatrics Raleigh North Carolina
United States Rhinelander Medical Center Rhinelander Wisconsin
United States Lewis Gale Clinic Salem Virginia
United States Memorial Medial Center Research Savannah Georgia
United States Pennridge Pediatrics Sellersville Pennsylvania
United States Pittsburgh Pediatric Research Upper St. Clair Pennsylvania
United States Vancouver Clinic Vancouver Washington

Sponsors (1)

Lead Sponsor Collaborator
Mead Johnson Nutrition

Countries where clinical trial is conducted

United States,  Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Early Infant Temperament Questionnaire 14 days No
Secondary Infant Characteristic Questionnaire 14 days No
Secondary Maternal Efficacy Questionnaire 14 days No
Secondary Mental Health Inventory Questionnaire 14 days No